Latest posts

An August 2021 appraisal of therapeutic-dose heparin in hospitalised COVID-19 patients without ICU-level organ support. It examines the multiplatform trial's benefits, bleeding-risk exclusions and composite outcome, and explains why these findings differ from those in critically ill patients.

Does cooling to 33°C improve outcomes after out-of-hospital cardiac arrest? This 2021 review of TTM2 compares hypothermia with actively managed normothermia, examining survival, neurological outcomes, adverse events and why fever control should not be confused with leaving temperature unmanaged.

What does access to a research paper cost its intended readers? Part two of this series explores purchasing power, publication fees and barriers faced in lower-income countries, then considers green open access, self-archiving and preprints as routes to wider dissemination.

Choosing a journal means thinking beyond impact factors. Part one of this series asks who needs your research, how regional readership and access costs affect its reach, and how authors can consider audiences in low- and middle-income countries when deciding where to publish.

What can point-of-care ultrasound add when a patient presents in shock? This 2021 review explores ultrasound protocols, diagnostic accuracy and patient outcomes, questioning a uniform scanning approach and considering how clinical context and pre-test probability can guide a focused examination.

Who gets the opportunity to become an author? Part three of the equitable publishing series explores fair authorship, mentorship and sponsorship, with practical ways to support junior researchers and widen opportunities beyond the colleagues already in our immediate networks.